Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level907 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (462)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01246986 | A Study of LY2157299 in Participants With Hepatocellular Carcinoma | completed | Phase 2 | 204 | Eli Lilly and CompanyINDUSTRY | 7 | Jan 12, 2021 | clinicaltrials |
| NCT04510935 | Effects of Anesthetic Methods on Hepatic Cancer Cell Function in Vitro | completed | N/A | 35 | RenJi HospitalOTHER | 1 | Jan 8, 2021 | clinicaltrials |
| NCT02511821 |
| Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery |
| completed |
| N/A |
| 22 |
| City of Hope Medical CenterOTHER |
| 1 |
| Jan 7, 2021 |
| clinicaltrials |
| NCT04692454 | Investigation of Immune Modulation by Modern Acupuncture in Gastroenterologic Cancers | completed | N/A | 5 | Taipei Medical University WanFang HospitalOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT04687280 | Comparison of Multiphase and Monophasic Arterial Hepatic MRI in the Detection of Arterial Enhancement of CHC Nodules(CHIC MultiA) | completed | — | 153 | University Hospital, AngersOTHER_GOV | 0 | Dec 29, 2020 | clinicaltrials |
| NCT02082210 | A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer | completed | Phase 1 / Phase 2 | 97 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 19, 2020 | clinicaltrials |
| NCT02988440 | Study of Safety and Tolerability of PDR001 in Combination With Sorafenib and to Identify the Maximum Tolerated Dose and/or Phase 2 Dose for This Combination in Advanced Hepatocellular Patients | completed | Phase 1 | 20 | Novartis PharmaceuticalsINDUSTRY | 8 | Dec 19, 2020 | clinicaltrials |
| NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 3 | 262 | Sun Yat-sen UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT01906021 | Study of New Software Used During Ablations | completed | N/A | 13 | National Institutes of Health Clinical Center (CC)NIH | 1 | Dec 10, 2020 | clinicaltrials |
| NCT01687673 | Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 29 | University of California, San FranciscoOTHER | 1 | Dec 7, 2020 | clinicaltrials |
| NCT04652947 | MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison | completed | — | 30 | University Hospital, AngersOTHER_GOV | 0 | Dec 3, 2020 | clinicaltrials |
| NCT03251443 | A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma | completed | Phase 2 | 34 | Peking Union Medical College HospitalOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT02239900 | Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors | completed | Phase 1 | 143 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT01198704 | Study of Factors Predicting Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma (HCC)(EFAPRE) | completed | — | 372 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 20, 2020 | clinicaltrials |
| NCT01595243 | Effects of Telephone Consultations on Discharged Liver Cancer | completed | N/A | 254 | National Taiwan University HospitalOTHER | 1 | Nov 16, 2020 | clinicaltrials |
| NCT01264705 | Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer | completed | Phase 1 / Phase 2 | 47 | University of Texas Southwestern Medical CenterOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT02658019 | Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 29 | Lynn Feun, MDOTHER | 1 | Nov 12, 2020 | clinicaltrials |
| NCT01258998 | Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Nov 4, 2020 | clinicaltrials |
| NCT03380130 | A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC(NASIR-HCC) | completed | Phase 2 | 41 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT03538028 | A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies | completed | Phase 1 | 22 | Incyte Biosciences International SàrlINDUSTRY | 1 | Oct 30, 2020 | clinicaltrials |
| NCT01835223 | Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery | completed | Phase 1 / Phase 2 | 33 | Roswell Park Cancer InstituteOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT01075321 | Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma | completed | Phase 1 / Phase 2 | 58 | Mayo ClinicOTHER | 1 | Oct 22, 2020 | clinicaltrials |
| NCT03007225 | Efficacy and Safety of Drug Eluting Beads TACE in Treatment of HCC in Egyptian Patients | completed | Phase 4 | 50 | Ain Shams UniversityOTHER | 0 | Oct 22, 2020 | clinicaltrials |
| NCT02288910 | Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver | completed | — | 7 | Rush University Medical CenterOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT01963429 | Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCC | completed | N/A | 144 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 6, 2020 | clinicaltrials |
| NCT04576572 | Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma | completed | — | 424 | Inonu UniversityOTHER | 1 | Oct 6, 2020 | clinicaltrials |
| NCT02519075 | 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE | completed | — | 14 | Istituto Clinico HumanitasOTHER | 1 | Oct 1, 2020 | clinicaltrials |
| NCT04568330 | Prevention of Hand-foot Skin Reaction | completed | N/A | 129 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 0 | Sep 29, 2020 | clinicaltrials |
| NCT02129829 | PROLIFICA - West African Treatment Cohort for Hepatitis B(WATCH) | completed | — | 1,079 | Imperial College LondonOTHER | 2 | Sep 28, 2020 | clinicaltrials |
| NCT04553458 | Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma | completed | — | 407 | Sohag UniversityOTHER | 0 | Sep 17, 2020 | clinicaltrials |
| NCT01938729 | Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma | completed | Phase 1 | 8 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 11, 2020 | clinicaltrials |
| NCT00132041 | Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis(ACRIN-6673) | completed | N/A | 51 | American College of Radiology Imaging NetworkNETWORK | 1 | Sep 10, 2020 | clinicaltrials |
| NCT03289533 | A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) | completed | Phase 1 | 22 | PfizerINDUSTRY | 1 | Sep 4, 2020 | clinicaltrials |
| NCT00049322 | Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery | completed | Phase 2 | 30 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 1, 2020 | clinicaltrials |
| NCT01774344 | Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma(RESORCE) | completed | Phase 3 | 573 | BayerINDUSTRY | 21 | Aug 20, 2020 | clinicaltrials |
| NCT01935700 | Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma | completed | Phase 2 | 15 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Aug 19, 2020 | clinicaltrials |
| NCT02461966 | Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta | completed | N/A | 300 | Sherief Abd-ElsalamOTHER | 1 | Aug 14, 2020 | clinicaltrials |
| NCT02069145 | Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer | completed | Phase 1 | 10 | OncoMed Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 11, 2020 | clinicaltrials |
| NCT03628651 | Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma | completed | — | 2,150 | Exact Sciences CorporationINDUSTRY | 7 | Aug 6, 2020 | clinicaltrials |
| NCT00005629 | Vaccine Therapy in Treating Patients With Liver Cancer | completed | Phase 1 / Phase 2 | 6 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT00022334 | Vaccine Therapy in Treating Patients With Liver Cancer | completed | Phase 1 / Phase 2 | 33 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT02753881 | Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer | completed | Phase 1 | 30 | Yale UniversityOTHER | 1 | Aug 3, 2020 | clinicaltrials |
| NCT01099631 | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread | completed | Phase 1 | 22 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT03140332 | Contribution of the Perfusion Scanner in the Prediction of the Tumor Control of Patients With Hepatocellular Carcinoma Treated With Sorafenib.(HCC-CTPerf) | completed | N/A | 2 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 20, 2020 | clinicaltrials |
| NCT02560779 | Trial of TRC105 and Sorafenib in Patients With HCC | completed | Phase 1 / Phase 2 | 27 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Jul 17, 2020 | clinicaltrials |
| NCT03183219 | Safety and Efficiency of γδ T Cell Against Liver Cancer | completed | Phase 1 / Phase 2 | 30 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT02927626 | Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma(YYFZTIHBVHCC) | completed | Early Phase 1 | 132 | Beijing Ditan HospitalOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT01871545 | Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI) | completed | N/A | 84 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Jul 9, 2020 | clinicaltrials |
| NCT02395523 | Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular Carcinoma | completed | N/A | 45 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 7, 2020 | clinicaltrials |
Data updated 24 days agoSource updated Jan 12, 2021source: clinicaltrials